BC |
breast cancer |
CTL |
cytotoxic T lymphocytes |
CTLA-4 |
cytotoxic T-lymphocyte-associated protein |
DC |
dendritic cell |
FGF |
fibroblast growth factor |
HER2 |
human epidermal growth factor receptor 2 |
HIF |
hypoxia-inducible transcription factor |
IC |
immune checkpoint |
ICIs |
immune checkpoint inhibitors |
IL-8 |
interleukin 8 |
Lag3 |
lymphocyte activation gene 3 |
LDHA |
lactate dehydrogenase |
MDSCs |
myeloid-derived suppressor cells |
MMPs |
matrix metalloproteinases |
pCR |
pathologic complete response |
PDGF |
platelet-derived growth factor |
PD-L1 |
programmed death-ligand 1 |
TAM |
M2-like protumor macrophages |
TGFβ-1 |
transforming growth factor beta-1 |
TILs |
tumor-infiltrating lymphocytes |
Tim-3 |
T-cell immunoglobulin mucin-3 |
TME |
tumor microenvironment |
TNBCs |
triple-negative BCs |
Tregs |
regulatory T cells |
VEGF |
vascular endothelial growth factor |